GeneDx Holdings Corp.
WGS
$166.95
$1.340.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.14% | 137.05% | 67.74% | 121.10% | 80.34% |
| Total Depreciation and Amortization | 9.19% | 18.65% | 8.19% | 1,020.55% | -31.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 429.10% | -57.56% | 22.70% | -352.54% | -47.17% |
| Change in Net Operating Assets | 50.10% | -360.64% | 143.62% | 7.21% | 60.85% |
| Cash from Operations | 458.75% | 331.30% | 162.04% | 89.34% | 89.34% |
| Capital Expenditure | -855.42% | -75.22% | -1,283.52% | -28.37% | -476.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 120.89% | 96.32% | -354.98% | 196.05% | 73.93% |
| Cash from Investing | 39.56% | -60.13% | -1,216.01% | 89.33% | 71.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -71.99% | -61.55% | -97.19% | -4.30% | 22.39% |
| Issuance of Common Stock | -18.34% | 775.18% | 60,854.17% | 171,221.05% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.91% | 188.49% | 3,231.96% | -34.14% | 1,633.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,101.76% | 7.29% | 190.53% | 120.67% | 102.62% |